Summary
- Profile Type
- Technology offer
- POD Reference
- TODE20231218010
- Term of Validity
- 18 December 2023 - 17 December 2025
- Company's Country
- Germany
- Type of partnership
- Research and development cooperation agreement
- Investment agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
-
Scientists at a German university have developed a sensor for measuring blood glucose levels. This allows the patient to continuously receive their sugar levels without having to take the measurement personally. The sensor does not need to be recalibrated, even if it is encapsulated after a foreign body reaction.
The university offers a lisence agreement or a technological cooperation in order to jointly refine the invention. - Full Description
-
Blood sugar monitoring is crucial for those with diabetes or other metabolic disorders. Blood sugar that is too high or too low can cause serious health problems, including cardiovascular disease, nerve damage, and even coma. A safe continuous blood sugar monitoring method that is also easy for patients involves an implanted sensor.
Scientists at a German university have developed a sensor that works reliably in the body despite encapsulation following foreign body reaction. It uses an enzyme-catalyzed detection reaction combined with a measurement at concentration equilibrium.
Among the sensor’s components are a microelectrode coated with a bioactive catalytic film and an oxygen-resistant enzyme as an active site. The enzymatic reaction is initiated with a short voltage pulse.
The university offers interested companies from the medical technology or biotechnology sectors a license agreement. A technological cooperation to further develop the invention jointly is also conceivable. - Advantages and Innovations
- The invention is a continuous glucose measurement systems. It relieves patients of the responsibility of constant blood sugar level monitoring, because this process is automated with the invention. Since the sensor is implanted, patients can avoid the unpleasant sensation of their skin being pierced. The prospective biosensor for automated blood sugar measurement has the advantage of delivering very reliable results. It requires no recalibration, even when encapsulated after a foreign body reaction.
- Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
Partner Sought
- Expected Role of a Partner
- The university offers interested companies from the medical technology or biotechnology sectors a license agreement. A technological cooperation to further develop the invention jointly is also conceivable.
- Type and Size of Partner
- SME 50 - 249
- SME 11-49
- SME <=10
- Other
- Big company
- Type of partnership
- Research and development cooperation agreement
- Investment agreement
Dissemination
- Technology keywords
- 06001013 - Medical Technology / Biomedical Engineering
- 06001005 - Diagnostics, Diagnosis
- Market keywords
- 05001007 - Other diagnostic
- 005001008 - Diagnostic test products and equipment
- Targeted countries
- All countries
